NCT02822911

Brief Summary

Alcohol misuse affects 5 million people in France. Even though the elderly are also concerned by this pathology, there is not much information about chronic alcohol misuse of this population in particular. Biological markers like gamma-glutamyltranspeptidase (GGT), mean corpuscular volume (MCV) and carbohydrate deficient transferrin (CDT) are usually used to detect alcohol abuse. As a biological marker of alcohol misuse, the specificity of the CDT is known to be superior to the GGT as well. However, when it comes to the elderly, alcoholism diagnosis tools are based on research of younger populations. This study aims to evaluate the benefit of the CDT to detect chronic alcohol use in the elderly.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
194

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 30, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 6, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

November 20, 2025

Status Verified

November 1, 2016

Enrollment Period

7 months

First QC Date

June 30, 2016

Last Update Submit

November 17, 2025

Conditions

Keywords

elderlychronic alcoholismCarbohydrate Deficient TransferrinBiological Detection / Diagnosis

Outcome Measures

Primary Outcomes (1)

  • Benefit of Carbohydrate Deficient Transferrin to detect chronic alcohol abuse in the elderly compared to usual clinical detection tools

    Analysis performed when at least 1 point at the AUDIT-C questionnaire, confirming presence of alcohol consumption

    Within 3 days after enrollment in the study

Secondary Outcomes (5)

  • Sensitivity and specificity of the disturbance of Gamma-glutamyltranspeptidase when presence of alcohol consumption, with at least 1 point in the AUDIT-C questionnaire

    Within 3 days after enrollment in the study

  • Sensitivity and specificity of the disturbance of Mean Corpuscular Volume when presence of alcohol consumption, with at least 1 point in the AUDIT-C questionnaire

    Within 3 days after enrollment in the study

  • Socio-economic characteristics of alcohol abusers : Socioprofessional category

    Within 3 days after enrollment in the study

  • Socio-economic characteristics of alcohol abusers : Education Category

    Within 3 days after enrollment in the study

  • Socio-economic characteristics of alcohol abusers : Way of life

    Within 3 days after enrollment in the study

Study Arms (1)

Alcohol Used Disorders Identification Test (AUDIT C)

OTHER

Submission of Audit-C questionnaire to all the patients of the study. When the result to the AUDIT-C questionnaire reaches at least 1 point, the analysis of the Carbohydrate deficient transferrin (CDT) is performed within 3 days after the beginning of the study. Results of Gamma glutamyl transpeptidase (GGT) and Mean Corpuscular Volume (MCV) performed as routine practice collected at the same time as the CDT analysis.

Behavioral: Alcohol Used Disorders Identification Test (AUDIT C)Procedure: Carbohydrate deficient transferrinProcedure: Gamma glutamyl transpeptidaseProcedure: Mean Corpuscular Volume

Interventions

The Audit-C questionnaire is a three item alcohol screen that can help identify persons who are hazardous drinkers or have active alcohol abuse disorders (including alcohol abuse or dependence). The AUDIT-C is a modified version of the 10 question AUDIT instrument. Score from 0 to 12. Each Audit-C question has a 5 answer choice, allotted points are from 0 to 4 points. In men, a score of 4 is considered as positive, optimal for identifying hazardous users or active alcohol abuse disorders. The same for 3 points in women.

Also known as: Audit-C questionnaire
Alcohol Used Disorders Identification Test (AUDIT C)

Blood sample to collect carbohydrate deficient transferrin (CDT) only if the Alcohol Used Disorders Identification Test (AUDIT C) reports at least 1 point.

Also known as: CDT
Alcohol Used Disorders Identification Test (AUDIT C)

Results of Gamma glutamyl transpeptidase (GGT) performed as routine practice collected only if the Alcohol Used Disorders Identification Test (AUDIT C) reaches at least 1 point.

Also known as: GGT
Alcohol Used Disorders Identification Test (AUDIT C)

Results of Mean Corpuscular Volume (MCV) performed as routine practice collected only if the Alcohol Used Disorders Identification Test (AUDIT C) reports at least 1 point.

Also known as: MCV
Alcohol Used Disorders Identification Test (AUDIT C)

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 60 years old
  • Patients hospitalized for a day or more in the Geriatrics Department of Mulhouse, GHRMSA :
  • Coming from home within 48 hours after admission to the GHRMSA
  • Study procedures performed within 72 hours after admission to the GHRMSA
  • Or new members of the General Practitioner Support Association of Alsace, France (translated in French as the "RAG") living in Mulhouse, Thann and Saint Louis cities (France) :
  • Living at home and joining the RAG between the 1st of March and the 31st of October 2016
  • Study Procedures performed within 3 days after enrollment in the study
  • Relative or helper available who usually visits the patient at home at least once a week
  • Absence of alcoholic excipient in the concomitant medication

You may not qualify if:

  • Age \< 60 years old
  • Admitted in the Geriatrics Department of Mulhouse after more than 48hours after admission to the GHRMSA
  • Presence of the following symptoms :
  • Hepatobiliary deficiency related to a primary biliary cirrhosis
  • Autoimmune or viral cirrhosis
  • Hepatocellular carcinoma
  • Congenital metabolic disorder in protein glycosylation
  • Known genetics variance in Tf B or D transferrin
  • Living in an elderly care institution
  • Already enrolled in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Reseau d'Appui aux Generalistes (RAG)

Colmar, 68000, France

Location

GHRMSA

Mulhouse, 68100, France

Location

Related Publications (1)

  • Schnell C (2016) Benefit of carbohydrate deficient transferrin in detecting chronic alcohol abuse in the elderly: study protocol for a multicentre, non-randomized, open-label study. Clin Transl Degener Dis 1(3):121-126.

    BACKGROUND

Related Links

MeSH Terms

Conditions

AlcoholismDisease

Interventions

Ethanolcarbohydrate-deficient transferringamma-GlutamyltransferaseErythrocyte Indices

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsAminoacyltransferasesAcyltransferasesTransferasesEnzymesEnzymes and CoenzymesHematologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Cecile Schnell, MD

    Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2016

First Posted

July 6, 2016

Study Start

March 1, 2016

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

November 20, 2025

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

Locations